The European Medicines Agency has recommended that three medicines manufactured by Pharmaceuticals International no longer be available in the EU due to possible cross-contamination. Read More
Hebei Yuxing Bio-Engineering, a Chinese producer of active pharmaceutical ingredients, received a warning letter from the FDA citing significant cGMP and data integrity issues discovered at its manufacturing plant. Read More
Option Care Enterprises received a warning letter from the FDA due to deficiencies in the production of sterile drugs and infusion products at its facility in Everett, Wash. Read More
FDAnews sorts through FDA recalls, import alerts and safety announcements, pulling the ones most relevant to the industry. Read More
Pan Drugs, located in India, has received a warning letter due to a series of cGMP violations found during an inspection last year. Read More
300 N Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 – Fax (703) 538-7676 – Toll free (888) 838-5578.
Copyright ©2016. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing